South Korea’s Digital Therapeutics (DTx) Market Expands Beyond Insomnia to ADHD, Depression, and Developmental Disorders
South Korea’s domestic digital therapeutics market is expanding rapidly beyond insomnia to treat clinical depression, attention-deficit/hyperactivity disorder (ADHD), and developmental disorders, according to data provided by the Ministry of Food and Safety (MFDS) to Medi:Gate News. As software-driven medical devices gain regulatory approval, the clinical landscape for digital health is shifting toward structured, application-based interventions. … Read more